Global Pharmacokinetics Services Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmacokinetics Services Revenue
• 1.4 Market by Type
  • 1.4.1 Global Pharmacokinetics Services Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Small Molecules Pharmacokinetics Services
  • 1.4.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
• 1.5 Market by Application
  • 1.5.1 Global Pharmacokinetics Services Market Share by Application: 2020 VS 2026
  • 1.5.2 Small & Medium Enterprise
  • 1.5.3 Large Enterprise
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmacokinetics Services Market Perspective (2015-2026)
• 2.2 Global Pharmacokinetics Services Growth Trends by Regions
  • 2.2.1 Pharmacokinetics Services Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmacokinetics Services Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmacokinetics Services Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmacokinetics Services Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmacokinetics Services Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmacokinetics Services Players by Market Size
  • 3.1.1 Global Top Pharmacokinetics Services Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmacokinetics Services Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmacokinetics Services Market Concentration Ratio
  • 3.2.1 Global Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Services Revenue in 2019
• 3.3 Pharmacokinetics Services Key Players Head office and Area Served
• 3.4 Key Players Pharmacokinetics Services Product Solution and Service
• 3.5 Date of Enter into Pharmacokinetics Services Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Pharmacokinetics Services Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Pharmacokinetics Services Market Size by Application (2015-2020)
• 5.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmacokinetics Services Market Size (2015-2020)
• 6.2 Pharmacokinetics Services Key Players in North America (2019-2020)
• 6.3 North America Pharmacokinetics Services Market Size by Type (2015-2020)
• 6.4 North America Pharmacokinetics Services Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmacokinetics Services Market Size (2015-2020)
• 7.2 Pharmacokinetics Services Key Players in Europe (2019-2020)
• 7.3 Europe Pharmacokinetics Services Market Size by Type (2015-2020)
• 7.4 Europe Pharmacokinetics Services Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmacokinetics Services Market Size (2015-2020)
• 8.2 Pharmacokinetics Services Key Players in China (2019-2020)
• 8.3 China Pharmacokinetics Services Market Size by Type (2015-2020)
• 8.4 China Pharmacokinetics Services Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmacokinetics Services Market Size (2015-2020)
• 9.2 Pharmacokinetics Services Key Players in Japan (2019-2020)
• 9.3 Japan Pharmacokinetics Services Market Size by Type (2015-2020)
• 9.4 Japan Pharmacokinetics Services Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmacokinetics Services Market Size (2015-2020)
• 10.2 Pharmacokinetics Services Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmacokinetics Services Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmacokinetics Services Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmacokinetics Services Market Size (2015-2020)
• 11.2 Pharmacokinetics Services Key Players in India (2019-2020)
• 11.3 India Pharmacokinetics Services Market Size by Type (2015-2020)
• 11.4 India Pharmacokinetics Services Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pharmacokinetics Services Market Size (2015-2020)
• 12.2 Pharmacokinetics Services Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pharmacokinetics Services Market Size by Type (2015-2020)
• 12.4 Central & South America Pharmacokinetics Services Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Evotec AG (Germany)
  • 13.1.1 Evotec AG (Germany) Company Details
  • 13.1.2 Evotec AG (Germany) Business Overview
  • 13.1.3 Evotec AG (Germany) Pharmacokinetics Services Introduction
  • 13.1.4 Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2015-2020))
  • 13.1.5 Evotec AG (Germany) Recent Development
• 13.2 Pacific BioLabs (US)
  • 13.2.1 Pacific BioLabs (US) Company Details
  • 13.2.2 Pacific BioLabs (US) Business Overview
  • 13.2.3 Pacific BioLabs (US) Pharmacokinetics Services Introduction
  • 13.2.4 Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.2.5 Pacific BioLabs (US) Recent Development
• 13.3 GVK Biosciences Private Limited (India)
  • 13.3.1 GVK Biosciences Private Limited (India) Company Details
  • 13.3.2 GVK Biosciences Private Limited (India) Business Overview
  • 13.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Introduction
  • 13.3.4 GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.3.5 GVK Biosciences Private Limited (India) Recent Development
• 13.4 Shanghai Medicilon Inc. (China)
  • 13.4.1 Shanghai Medicilon Inc. (China) Company Details
  • 13.4.2 Shanghai Medicilon Inc. (China) Business Overview
  • 13.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Introduction
  • 13.4.4 Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.4.5 Shanghai Medicilon Inc. (China) Recent Development
• 13.5 Pharmaceutical Product Development, LLC (US)
  • 13.5.1 Pharmaceutical Product Development, LLC (US) Company Details
  • 13.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
  • 13.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Introduction
  • 13.5.4 Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.5.5 Pharmaceutical Product Development, LLC (US) Recent Development
• 13.6 Charles River Laboratories International, Inc. (US)
  • 13.6.1 Charles River Laboratories International, Inc. (US) Company Details
  • 13.6.2 Charles River Laboratories International, Inc. (US) Business Overview
  • 13.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Introduction
  • 13.6.4 Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.6.5 Charles River Laboratories International, Inc. (US) Recent Development
• 13.7 PAREXEL International Corporation (US)
  • 13.7.1 PAREXEL International Corporation (US) Company Details
  • 13.7.2 PAREXEL International Corporation (US) Business Overview
  • 13.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Introduction
  • 13.7.4 PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.7.5 PAREXEL International Corporation (US) Recent Development
• 13.8 Eurofins Scientific, Inc. (Luxembourg)
  • 13.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Details
  • 13.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
  • 13.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Introduction
  • 13.8.4 Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Development
• 13.9 Frontage Labs (US)
  • 13.9.1 Frontage Labs (US) Company Details
  • 13.9.2 Frontage Labs (US) Business Overview
  • 13.9.3 Frontage Labs (US) Pharmacokinetics Services Introduction
  • 13.9.4 Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.9.5 Frontage Labs (US) Recent Development
• 13.10 SGS SA (Switzerland)
  • 13.10.1 SGS SA (Switzerland) Company Details
  • 13.10.2 SGS SA (Switzerland) Business Overview
  • 13.10.3 SGS SA (Switzerland) Pharmacokinetics Services Introduction
  • 13.10.4 SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 13.10.5 SGS SA (Switzerland) Recent Development
• 13.11 LGC Limited (UK)
  • 10.11.1 LGC Limited (UK) Company Details
  • 10.11.2 LGC Limited (UK) Business Overview
  • 10.11.3 LGC Limited (UK) Pharmacokinetics Services Introduction
  • 10.11.4 LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 10.11.5 LGC Limited (UK) Recent Development
• 13.12 Creative Bioarray (US)
  • 10.12.1 Creative Bioarray (US) Company Details
  • 10.12.2 Creative Bioarray (US) Business Overview
  • 10.12.3 Creative Bioarray (US) Pharmacokinetics Services Introduction
  • 10.12.4 Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 10.12.5 Creative Bioarray (US) Recent Development
• 13.13 Certara, L.P. (Germany)
  • 10.13.1 Certara, L.P. (Germany) Company Details
  • 10.13.2 Certara, L.P. (Germany) Business Overview
  • 10.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Introduction
  • 10.13.4 Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2015-2020)
  • 10.13.5 Certara, L.P. (Germany) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer